These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12752492)

  • 1. Type 2 diabetes presenting as diabetic ketoacidosis in adolescence.
    Valabhji J; Watson M; Cox J; Poulter C; Elwig C; Elkeles RS
    Diabet Med; 2003 May; 20(5):416-7. PubMed ID: 12752492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic ketoacidosis in association with acanthosis nigricans.
    Ramamrutham RA; Westphal SA
    Endocr Pract; 2000; 6(2):159-61. PubMed ID: 11421534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic acidosis in an Afro-Caribbean man with hyperpigmentation.
    Darko DA; Chan NN; Jackson A; Peiris C; O'Shea D
    Postgrad Med J; 2000 Jul; 76(897):429, 439-40. PubMed ID: 10878209
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical problem-solving. The importance of a name.
    Pinhas-Hamiel O; Zeitler P
    N Engl J Med; 1999 May; 340(18):1418-21. PubMed ID: 10228194
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetic ketoacidosis in young obese Japanese men.
    Yamada K; Nonaka K
    Diabetes Care; 1996 Jun; 19(6):671. PubMed ID: 8725872
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic approach in insulin resistance with acanthosis nigricans.
    Tankova T; Koev D; Dakovska L; Kirilov G
    Int J Clin Pract; 2002 Oct; 56(8):578-81. PubMed ID: 12425366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of pancreatic beta-cell function in obese children with acanthosis nigricans].
    Liang XJ; Zhu C; Yan C; Ni GC; Liu ZL; Du ZM; Li M
    Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):405-7. PubMed ID: 15265420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises.
    Umpierrez GE; Clark WS; Steen MT
    Diabetes Care; 1997 Apr; 20(4):479-83. PubMed ID: 9096964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acanthosis nigricans and diabetic ketoacidosis.
    Bau CT; Sheu WH; Song YM; Tseng LN; Wang CC
    Diabetes Care; 1997 Jul; 20(7):1202. PubMed ID: 9203462
    [No Abstract]   [Full Text] [Related]  

  • 11. Diabetic ketoacidosis in obese African-Americans.
    Umpierrez GE; Casals MM; Gebhart SP; Mixon PS; Clark WS; Phillips LS
    Diabetes; 1995 Jul; 44(7):790-5. PubMed ID: 7789647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive insulin therapy combined with metformin in obese type 2 diabetic patients.
    Fritsche A; Schmülling RM; Häring HU; Stumvoll M
    Acta Diabetol; 2000 Mar; 37(1):13-8. PubMed ID: 10928231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do obese children with diabetic ketoacidosis have type 1 or type 2 diabetes?
    Low JC; Felner EI; Muir AB; Brown M; Dorcelet M; Peng L; Umpierrez GE
    Prim Care Diabetes; 2012 Apr; 6(1):61-5. PubMed ID: 22230097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical and hormonal (C-peptide and glucagon) profile and liability to ketoacidosis during nutritional rehabilitation in Ethiopian patients with malnutrition-related diabetes mellitus.
    Abdulkadir J; Mengesha B; Welde Gebriel Z; Keen H; Worku Y; Gebre P; Bekele A; Urga K; Taddesse AS
    Diabetologia; 1990 Apr; 33(4):222-7. PubMed ID: 2112100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combined effect of triple therapy with rosiglitazone, metformin, and insulin aspart in type 2 diabetic patients.
    Poulsen MK; Henriksen JE; Hother-Nielsen O; Beck-Nielsen H
    Diabetes Care; 2003 Dec; 26(12):3273-9. PubMed ID: 14633813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of serum basal C peptide levels amongst Arab patients with diabetes mellitus.
    Abdella N; Luqman W; Hassan M; Salman A
    Diabetes Res; 1988 Sep; 9(1):47-50. PubMed ID: 3149222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes.
    Garg SK; Henry RR; Banks P; Buse JB; Davies MJ; Fulcher GR; Pozzilli P; Gesty-Palmer D; Lapuerta P; Simó R; Danne T; McGuire DK; Kushner JA; Peters A; Strumph P
    N Engl J Med; 2017 Dec; 377(24):2337-2348. PubMed ID: 28899222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with insulin discontinuation in subjects with ketosis-prone diabetes but preserved beta-cell function.
    Maldonado MR; Otiniano ME; Cheema F; Rodriguez L; Balasubramanyam A
    Diabet Med; 2005 Dec; 22(12):1744-50. PubMed ID: 16401322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetes mellitus, but which type?].
    Hoekstra JB; de Koning EJ
    Ned Tijdschr Geneeskd; 2004 Apr; 148(16):761-4. PubMed ID: 15129562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of Caucasian type 2 diabetic patients during ketoacidosis and at follow-up.
    Pitteloud N; Philippe J
    Schweiz Med Wochenschr; 2000 Apr; 130(16):576-82. PubMed ID: 10842773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.